| Literature DB >> 25390941 |
Jiuqing Cheng1, Claudia González-Vallejo1.
Abstract
The single parameter hyperbolic model has been frequently used to describe value discounting as a function of time and to differentiate substance abusers and non-clinical participants with the model's parameter k. However, k says little about the mechanisms underlying the observed differences. The present study evaluates several alternative models with the purpose of identifying whether group differences stem from differences in subjective valuation, and/or time perceptions. Using three two-parameter models, plus secondary data analyses of 14 studies with 471 indifference point curves, results demonstrated that adding a valuation, or a time perception function led to better model fits. However, the gain in fit due to the flexibility granted by a second parameter did not always lead to a better understanding of the data patterns and corresponding psychological processes. The k parameter consistently indexed group and context (magnitude) differences; it is thus a mixed measure of person and task level effects. This was similar for a parameter meant to index payoff devaluation. A time perception parameter, on the other hand, fluctuated with contexts in a non-predicted fashion and the interpretation of its values was inconsistent with prior findings that supported enlarged perceived delays for substance abusers compared to controls. Overall, the results provide mixed support for hyperbolic models of intertemporal choice in terms of the psychological meaning afforded by their parameters.Entities:
Mesh:
Year: 2014 PMID: 25390941 PMCID: PMC4229090 DOI: 10.1371/journal.pone.0111378
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Subjective Value of A from c-, Rachlin- with parameters k = 0.5 and 2; c = 1 and 10; s = 0.5. A = 100 and 1000.
Figure 2Rachlin- and Green-Models with varying parameters s = 0.5 and 1.5; k = 0.5 and 2. A = 100 and 1000.
Demographic Information of Participants and Experimental Design.
| Basic demographic information of participants | General information of experimental design | |||||||
| Study | N | Mean age | Gender | Mean education | Substance abusers or non-clinical participants | Rewards | Delays | Staircase or titration |
| Bickel, Yi, Landes, Hill & Baxter (2010) condition A | 27 | 38.6 | 20 males and 7 females | 12.2 | 20 cocaine users, 5 methamphetamine users and 2 mixed users | Real $100 | 1 day, 1 week, 1 month and 6 months | Staircase |
| Bickel, Yi, Landes, Hill & Baxter (2010) condition B and C | 54 | Same as above | Hypothetical $100 and hypothetical $1,000, respectively | 1 day, 1 week, 1 month, 6 months, 1 year, 5 years and 25 years | Same as above | |||
| Odum, Madden, Badger & Bickel (2000) | 17 | 32.7 | 11 males and 6 females | 12.8 | Opium (non-needle sharing) | Hypothetical $1,000 | 1 week, half a month, 1 month, 6 months, 1 year, 5 years and 25 years | Staircase |
| Cheng, Lu, Han, Gonzalez-Vallejo & Sui (2012) heroin abusers | 112 | 34.1 | 41 males and 15 females | 10.2 | Herion abusers | Hypothetical 200RMB and 50,000RMB (Chinese currency) | 1 day, 1 week, 1 month, 6 months, 1 year, 5 years, 10 years and 20 years | Titration |
| Cheng, Lu, Han, Gonzalez-Vallejo & Sui (2012) controls | 112 | 36.0 | Same as above | 10.6 | non-clinical participants | Same as above | ||
| Estle, Green, Myerson & Holt (2006, Exp 1) | 40 | 19.5 | 7 males and 13 females | undergraduate | non-clinical participants | Hypothetical $200 and $40,000 | 1 month, 6 months, 1 year, 3 years, 5 years, 10 years and 20 years | Titration |
| Estle, Green, Myerson & Holt (2006, Exp 3) | 81 | 19.2 | 15 males and 12 females | undergraduate | non-clinical participants | Hypothetical $100, $20,000 and $60,000 | 1 month, 6 months, 1 year, 3 years, 5 years, 8 years, 12 years, and 20 years | Titration |
| Cheng & Gonzalez-Vallejo (unpublished data) | 28 | NA | NA | undergraduate | non-clinical participants | Hypothetical $600 | 1, 10, 30, 50, 100, and 150 days | Staircase |
*: The number of actual discounting curves in each condition that was obtained from different individuals.
Median R2 for SA Group in Each Study.
| Study | Bickel A | Bickel B | Bickel C | Odum | Cheng Heroin | Cheng Heroin |
| Magnitude | 100 | 100 | 1000 | 1000 | 200 | 50000 |
| Base-model | .000 (.88) | .753 (.90) | .471 (.90) | .777 (.81) | .855 (.78) | .829 (.77) |
|
| .817 (.76) | .753 (.90) | .840 (.50) | .921 (.28) | .959 (.05) | .884 (.09) |
| Rachlin-model | .700 (.66) | .882 (.40) | .853 (.57) | .940 (.11) | .964 (.03) | .967 (.04) |
| Green-model | .848 (.89) | .855 (.55) | .859 (.68) | .945 (.16) | .941 (.06) | .963 (.08) |
Note: Numbers in parentheses are the interquartile range.
Median R2 for NC Group in Each Study.
| Study | Estle 1 | Estle 1 | Estle 3 | Estle 3 | Estle 3 | Cheng Control | Cheng Control | OU |
| Magnitude | 200 | 40000 | 100 | 20000 | 60000 | 200 | 50000 | 600 |
| Base-model | .922 (.26) | .898 (.11) | .884 (.11) | .844 (.28) | .881 (.31) | .923 (.23) | .930 (.09) | .921 (.15) |
|
| .956 (.17) | .922 (.11) | .930 (.23) | .895 (.16) | .912 (.43) | .980 (.03) | .979 (.03) | .952 (.05) |
| Rachlin-model | .962 (.08) | .939 (.09) | .946 (.18) | .921 (.18) | .947 (.30) | .989 (.02) | .981 (.03) | .978 (.04) |
| Green-model | .949 (.07) | .949 (.07) | .938 (.17) | .901 (.20) | .948 (.23) | .981 (.04) | .975 (.04) | .964 (.05) |
Note: Numbers in parentheses are the interquartile range.
Median R2 Within SA and NC.
| SA | NC | |
|
| .906 (.192) | .960 (.070) |
| Rachlin-model | .953 (.119) | .971 (.058) |
| Green-model | .937 (.133) | .964 (.073) |
Figure 3Scatter Plots of Predicted and Observed Indifference Points for Each Model in each SA and NC Groups.
Linear Regression of Predictive Validity of Models in SA and NC.
| slope | intercept |
| |
|
| .883 | 592.50 | .873 |
| Rachlin-model SA | .979 | −48.846 | .942 |
| Green-model SA | .978 | −99.155 | .883 |
|
| .969 | 533.763 | .940 |
| Rachlin-model NC | .979 | 27.628 | .969 |
| Green-model NC | .972 | 54.236 | .957 |
Median and Mean Values of Parameters in Each Study.
|
| Rachlin-model | Green-model | |||||
|
|
|
|
|
|
| ||
| Bickel ASA | Median | .004 (.03) | 1.133 (.50) | .096 (.43) | .257 (.60) | 1.251 (6.9) | .273 (.43) |
| Mean | .020 (.03) | 1.589 (1.3) | .456 (1.0) | .474 (.63) | 15.14 (29.4) | 1.651 (4.68) | |
| Bickel BSA | Median | .002 (.009) | 1.092 (.20) | .041(.13) | .486 (.55) | .040 (.613) | .252 (.44) |
| Mean | .058 (.009) | 2.839 (8.46) | 1.468 (7.2) | .603 (.51) | 4.564 (10.9) | .307 (.27) | |
| Bickel CSA | Median | .002 (.009) | 1.092 (.38) | .066 (.24) | .423 (.49) | .178 (1.6) | .288 (.59) |
| Mean | .030 (.08) | 1.330 (.83) | .269 (.67) | .604 (.91) | 5.112 (16.1) | .399 (.36) | |
| OdumSA | Median | .013 (.641) | 1.067 (.32) | .259 (2.4) | .980 (1.6) | 3.97(10.7) | .175 (85) |
| Mean | 2.41 (6.81) | 1.511 (1.53) | 3.089 (7.8) | 1.438 (1.5) | 10.27 (16.2) | .483 (.50) | |
| Cheng Heroin smallSA | Median | .008 (.007) | 1.276 (.35) | .117 (.24) | .512 (.27) | .122 (.72) | .333 (.17) |
| Mean | .010 (.01) | 1.527 (.91) | .270 (.43) | .556 (.19) | 1.965 (5.25) | .382 (.20) | |
| Cheng Heroin largeSA | Median | .002 (.002) | 1.151 (.23) | .051 (.11) | .520 (.23) | .047 (.23) | .286 (.13) |
| Mean | .002 (.001) | 1.292 (.39) | .153 (2.7) | .539 (.32) | .754 (3.25) | .260 (.12) | |
| Estle 1 smallNC | Median | .054 (.10) | 1.058 (.39) | .193 (.42) | .867 (.56) | .268 (1.30) | .767 (.71) |
| Mean | .109 (.19) | 1.202 (.40) | .265 (.42) | .878 (.47) | 1.122 (2.5) | .694 (.41) | |
| Estle 1 largeNC | Median | .009 (.02) | 1.032 (.07) | .024 (.07) | .774 (.37) | .035 (.15) | .419 (.76) |
| Mean | .040 (.09) | 1.046 (.13) | .070 (.11) | .864 (.38) | .150 (.266) | .920 (1.7) | |
| Estle 3 smallNC | Median | .051 (.17) | 1.192 (.38) | .205 (.20) | .641 (.43) | .549 (1.15) | .439 (.52) |
| Mean | .114 (.16) | 1.270 (.37) | .316 (.32) | .705 (.27) | 1.106 (.25) | .694 (.63) | |
| Estle 3 mediumNC | Median | .007 (.02) | 1.026 (.08) | .020 (.03) | .871 (.45) | .027 (.12) | .550 (.87) |
| Mean | .013 (.02) | 1.056 (.10) | .037 (.06) | .834 (.38) | .508 (1.84) | 3.76 (13.3) | |
| Estle 3 largeNC | Median | .006 (.02) | 1.019 (.13) | .012 (.05) | .846 (1.04) | .019 (.27) | .732 (37.4) |
| Mean | .013 (.01) | 1.072 (.16) | .066 (.10) | 1.004 (.61) | .344 (1.2) | 17.40 (26.1) | |
| Cheng Control smallNC | Median | .004 (.002) | 1.040 (.07) | .012 (.02) | .808 (.20) | .009 (.01) | .653 (.22) |
| Mean | .005 (.004) | 1.088 (.16) | .043 (.01) | .789 (.17) | .187 (.95) | .586 (.23) | |
| Cheng Control largeNC | Median | .001 (.0004) | 1.061 (.06) | .008 (.01) | .663 (.20) | .005 (.005) | .381 (.19) |
| Mean | .0009 (.0005) | 1.067 (.06) | .014 (.02) | .753 (.27) | .008 (.06) | .535 (1.2) | |
| OUNC | Median | .008 (.01) | 1.036 (.09) | .014 (.04) | .844 (.44) | .008 (.02) | .525 (1.61) |
| Mean | .011 (.01) | 1.056 (.08) | .041 (.06) | .832 (.30) | .079 (.23) | 3.045 (7.2) | |
| SA | Median | .003 (.009) | 1.157 (.34) | .086 (.26) | .503 (.38) | .120 (4.07) | .282 (.31) |
| Mean | .346 (2.74) | 1.645 (3.06) | 3.078 (9.8) | .419 (1.36) | .754 (3.9) | .958 (4.7) | |
| NC | Median | .004 (.015) | 1.043 (.95) | .016 (.05) | .771 (.34) | .012 (.09) | .465 (.54) |
| Mean | .041 (.23) | 1.099 (.21) | .355 (1.35) | 1.742 (6.2) | .086 (.19) | .827 (.35) | |
| Total | Median | .004 (.01) | 1.071 (.21) | .032 (.14) | .646 (.40) | .024 (.16) | .347 (.44) |
| Mean | .173 (1.82) | 1.278 (1.99) | .382 (2.61) | .725 (.52) | .468 (1.37) | .865 (3.24) | |
Note: Numbers in parentheses are IQR and standard deviation for median and mean values, respectively. SA: median and mean of parameter values computed across all cases in studies having substance abusers; NC: median and mean of parameter values computed across all cases in studies having non-clinical participants. The Total has the median and mean computed across all cases and studies. When SA and NC are superscripts, they indicate whether the study contains substance abusers or non-clinical people.
Percentage of Deviation of Parameters From The Value of 1 in Each Study.
|
| Rachlin- | Green- | |
| Bickel ASA | 85*** | 93*** | 85** |
| Bickel BSA | 85*** | 89*** | 81** |
| Bickel CSA | 81*** | 93*** | 89** |
| OdumSA | 65 | 53 | 65 |
| Cheng Heroin smallSA | 96*** | 98** | 100*** |
| Cheng Heroin largeSA | 80* | 75* | 75* |
| Estle 1 smallNC | 70 | 60 | 70 |
| Estle 1 largeNC | 80* | 75* | 75* |
| Estle 3 smallNC | 81** | 85** | 85** |
| Estle 3 mediumNC | 78** | 74* | 67 |
| Estle 3 largeNC | 63 | 59 | 56 |
| Cheng Control smallNC | 88*** | 91*** | 100*** |
| Cheng Control largeNC | 84*** | 89*** | 93*** |
| OUNC | 82** | 71* | 71* |
| SA | 89*** | 92*** | 90*** |
| NC | 80*** | 82*** | 79*** |
| Total | 84*** | 84*** | 86*** |
Note: *p<.05; **p<.01; ***p<.001. SA: percentage computed across all cases in studies with substance abuse individuals; NC: percentage computed across all cases in studies with non-clinical individuals. Total: percentage computed across all cases in all studies. When SA and NC are superscripts, they indicate whether the study contains substance abusers or non-clinical people.
Spearman Rank Correlations Between the Model Parameters.
|
| Rachlin-( | Green-( | |
| Bickel ASA | .181 | −.239 | −.505** |
| Bickel BSA | −.161 | −.363 | −.733*** |
| Bickel CSA | .204 | −.243 | −.541** |
| OdumSA | −.397 | −.162 | −.834*** |
| Cheng Heroin smallSA | .266* | −.845*** | −.845*** |
| Cheng Heroin largeSA | −.273* | −.977*** | −.640*** |
| Estle 1 smallNC | −.429 | −.442 | −.829*** |
| Estle 1 largeNC | −.053 | −.439 | −.433 |
| Estle 3 smallNC | −.266 | −.447* | −.584** |
| Estle 3 mediumNC | −.041 | −.597** | −.814*** |
| Estle 3 largeNC | −.410* | −.808*** | −.925*** |
| Cheng Control smallNC | .140 | −.903*** | −.353** |
| Cheng Control largeNC | .492*** | −.963*** | −.374** |
| OUNC | 0.0 | −.822*** | −.455* |
| SA | .078 | −.621*** | −.494*** |
| NC | −.018 | −.408*** | −.583*** |
| Total | −.012 | −.620*** | −.555*** |
Note: *p<.05; **p<.01; ***p<.001. SA: correlation computed across cases in studies with substance abusers. NC: correlation computed across all cases in studies with non-clinical individuals. Total: correlation computed across all cases in all studies. When SA and NC are superscripts, they indicate whether the study contains substance abusers or non-clinical people.
Spearman Correlations Between AUC and Estimated Parameters.
| Base | c model |
| Rachlin- | Rachlin- | Green- | Green- | |
| Bickel ASA | −.971*** | −.718*** | −.063 | −.692** | −.410* | −.199 | −.479* |
| Bickel BSA | −.955*** | −.903*** | −.075 | −.269 | −.676*** | .162 | −.662*** |
| Bickel CSA | −.957*** | −.958*** | −.284 | −.467* | −.665*** | .087 | −.731*** |
| OdumSA | −.912*** | −.765*** | −.044 | −.873*** | −.044 | −.345 | −.010 |
| Cheng Heroin smallSA | −.793*** | −.788*** | −.485*** | −.608*** | .305*** | −.615*** | .274* |
| Cheng Heroin largeSA | −.687*** | −.736*** | −.116 | −.224 | .068 | −.209 | −.182 |
| Estle 1 smallNC | −.937*** | −.973*** | .355 | −.532* | −.380 | −.098 | −.329 |
| Estle 1 largeNC | −.985*** | −.983*** | .015 | −.580** | −.347 | −.302 | −.671** |
| Estle 3 smallNC | −.990*** | −.940*** | .081 | −.501** | −.405* | −.194 | −.548** |
| Estle 3 mediumNC | −.992*** | −.993*** | −.015 | −.299 | −.531** | .161 | −.634*** |
| Estle 3 largeNC | −.979*** | −.968*** | .263 | −.064 | −.466* | .244 | −.526** |
| Cheng Control smallNC | −.510*** | −.807*** | −.179 | −.524*** | .300* | −.563*** | −.106 |
| Cheng Control largeNC | −.968*** | −.789*** | −.500*** | −.586*** | .412** | −.600*** | −.196 |
| OUNC | −.993*** | −.980*** | −.071 | −.207 | −.310 | .137 | −.414* |
| SA | −.779*** | −.792*** | −.243*** | −.405*** | −.363*** | −.075 | −.462*** |
| NC | −.131* | −.241*** | −.121 | −.190** | −.069 | −.047 | −.279*** |
| Total | −.471*** | −.442*** | −.274*** | −.371*** | −.059 | −.185*** | −.226*** |
Note: *p<.05; **p<.01; ***p<.001. SA: correlation computed across cases in studies with substance abusers. NC: correlation computed across all cases in studies with non-clinical individuals. Total: correlation computed across all cases in all studies. When SA and NC are superscripts, they indicate whether the study contains substance abusers or non-clinical people.
Partial Spearman Rank Correlations Between Model Parameters and AUC.
|
|
| Rachlin- | Rachlin- | Green- | Green- | |
| Bickel ASA | −.776*** | −.690*** | −.892*** | −.820*** | −.477* | −.630** |
| Bickel BSA | −.930*** | −.520** | −.750*** | −.862*** | −.635*** | −.810*** |
| Bickel CSA | −.959*** | −.317 | −.868*** | −.908*** | −.537** | −.816*** |
| OdumSA | −.853*** | −.588* | −.892*** | −.384* | −.639** | −.573* |
| Cheng Heroin smallSA | −.770*** | −.460*** | −.688*** | −.492*** | −.744*** | −.580*** |
| Cheng Heroin largeSA | −.804*** | −.486*** | −.749*** | −.735*** | −.430** | −.420** |
| Estle 1 smallNC | −.972*** | −.297 | −.845*** | −.811*** | −.701** | −.736** |
| Estle 1 largeNC | −.984*** | −.205 | −.870*** | −.823*** | −.887*** | −.933*** |
| Estle 3 smallNC | −.955*** | −.512** | −.834*** | −.812*** | −.758*** | −.831*** |
| Estle 3 mediumNC | −.994*** | −.455* | −.906*** | −.926*** | −.794*** | −.879*** |
| Estle 3 largeNC | −.978*** | −.586** | −.847*** | −.882*** | −.749*** | −.814*** |
| Cheng Control smallNC | −.802*** | −.112 | −.618*** | −.474*** | −.645*** | −.393** |
| Cheng Control largeNC | −.721*** | −.209 | −.772*** | −.700*** | −.567*** | −.740*** |
| OUNC | −.983*** | −.362 | −.853*** | −.862*** | −.063 | −.398* |
| SA | −.799*** | −.298*** | −.722*** | −.708*** | −.521*** | −.651*** |
| NC | −.245*** | −.129* | −.285*** | −.227*** | −.183** | −.327*** |
| Total | −.463*** | −.311*** | −.520*** | −.396*** | −.383*** | −.402*** |
Note: *p<.05; **p<.01; ***p<.001. SA: correlation computed across cases in studies with substance abusers. NC: correlation computed across all cases in studies with non-clinical individuals. Total: correlation computed across all cases in all studies. When SA and NC are superscripts, they indicate whether the study contains substance abusers or non-clinical people. When SA and NC are superscripts, they indicate whether the study contains substance abusers or non-clinical people.
Meta-Analysis of Effect Size (Cohen's d) When Testing Magnitude Effect.
| Parameters | Avg( | SD( | 95% CI |
|
| 0.851 | 0.472 | [.415–1.29] |
|
| 0.312 | 0.141 | [.132–.492] |
|
| 0.861 | 0.53 | [.377–1.35] |
|
| 0.616 | 0.273 | [.343–.899] |
| Rachlin - | 0.39 | 0.0 | [.283–.497] |
| Rachlin- | −0.087 | 0.529 | [−.569–.395] |
| Green- | 0.317 | 0.035 | [.184–.450] |
| Green- | −0.008 | 0.674 | [−.613–.597] |
Note. a: According to Hunter & Schmidt (2004), the population variance of effect size (δ) is obtained by subtracting variance due to sampling error from observed variance adjusted by sample size.
Median and Mean Values of the Parameters of Heroin and Control Participants in [30].
|
| Rachlin-model | Green-model | |||||
|
|
|
|
|
|
| ||
| HeroinS | Median | .008 (.007) | 1.276 (.35) | .117 (.24) | .512 (.27) | .122 (.72) | .333 (.17) |
| Mean | .010 (.01) | 1.527 (.91) | .270 (.43) | .556 (.19) | 1.965 (5.25) | .382 (.20) | |
| HeroinL | Median | .002 (.002) | 1.151 (.23) | .051 (.11) | .520 (.23) | .047 (.23) | .286 (.13) |
| Mean | .002 (.001) | 1.292 (.39) | .153 (2.7) | .539 (.32) | .754 (3.25) | .260 (.12) | |
| ControlS | Median | .004 (.002) | 1.040 (.07) | .012 (.02) | .808 (.20) | .009 (.01) | .653 (.22) |
| Mean | .005 (.004) | 1.088 (.16) | .043 (.01) | .789 (.17) | .187 (.95) | .586 (.23) | |
| ControlL | Median | .001 (.0004) | 1.061 (.06) | .008 (.01) | .663 (.20) | .005 (.005) | .381 (.19) |
| Mean | .0009(.0005) | 1.067 (.06) | .014 (.02) | .753 (.27) | .008 (.06) | .535 (1.2) | |
Note: Superscripts S and L index small and large payoffs. Numbers in parentheses are IQR for median, and standard deviation for means; means computed without outliers.